Vaccine Development against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges
- PMID: 29520257
- PMCID: PMC5827553
- DOI: 10.3389/fmicb.2018.00266
Vaccine Development against Zoonotic Hepatitis E Virus: Open Questions and Remaining Challenges
Abstract
Hepatitis E virus (HEV) is a fecal-orally transmitted foodborne viral pathogen that causes acute hepatitis in humans and is responsible for hepatitis E outbreaks worldwide. Since the discovery of HEV as a zoonotic agent, this virus has been isolated from a variety of hosts with an ever-expanding host range. Recently, a subunit HEV vaccine developed for the prevention of human disease was approved in China, but is not yet available to the rest of the world. Meanwhile, notable progress and knowledge has been made and revealed in recent years to better understand HEV biology and infection, including discoveries of quasi-enveloped HEV virions and of a new function of the HEV-ORF3 product. However, the impact of these new findings on the development of a protective vaccine against zoonotic HEV infection requires further discussion. In this review, hallmark characteristics of HEV zoonosis, the history of HEV vaccine development, and recent discoveries in HEV virology are described. Moreover, special attention is focused on quasi-enveloped HEV virions and the potential role of the HEV-ORF3 product as antibody-neutralization target on the surface of quasi-enveloped HEV virions to provide new insights for the future development of improved vaccines against zoonotic HEV infection.
Keywords: HEV vaccine; HEV-ORF3 product; hepatitis E virus; quasi-enveloped virion; subunit vaccine; zoonosis.
Figures



Similar articles
-
Open reading frame 3 protein of hepatitis E virus: Multi-function protein with endless potential.World J Gastroenterol. 2021 May 28;27(20):2458-2473. doi: 10.3748/wjg.v27.i20.2458. World J Gastroenterol. 2021. PMID: 34092969 Free PMC article. Review.
-
Palmitoylation-dependent association with Annexin II directs hepatitis E virus ORF3 sorting into vesicles and quasi-enveloped virions.Proc Natl Acad Sci U S A. 2025 Jan 7;122(1):e2418751122. doi: 10.1073/pnas.2418751122. Epub 2024 Dec 30. Proc Natl Acad Sci U S A. 2025. PMID: 39793027 Free PMC article.
-
Molecular Biology and Infection of Hepatitis E Virus.Front Microbiol. 2016 Sep 7;7:1419. doi: 10.3389/fmicb.2016.01419. eCollection 2016. Front Microbiol. 2016. PMID: 27656178 Free PMC article. Review.
-
Zoonotic Hepatitis E Virus: An Ignored Risk for Public Health.Front Microbiol. 2017 Dec 4;8:2396. doi: 10.3389/fmicb.2017.02396. eCollection 2017. Front Microbiol. 2017. PMID: 29255453 Free PMC article. Review.
-
The Hepatitis E Virus Open Reading Frame 2 Protein: Beyond Viral Capsid.Front Microbiol. 2021 Oct 7;12:739124. doi: 10.3389/fmicb.2021.739124. eCollection 2021. Front Microbiol. 2021. PMID: 34690982 Free PMC article. Review.
Cited by
-
In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus.In Silico Pharmacol. 2021 May 4;9(1):35. doi: 10.1007/s40203-021-00093-y. eCollection 2021. In Silico Pharmacol. 2021. PMID: 33959472 Free PMC article.
-
Trends and projections of Hepatitis A incidence in eastern China from 2007 to 2021: an age-period-cohort analysis.Front Public Health. 2024 Dec 4;12:1476748. doi: 10.3389/fpubh.2024.1476748. eCollection 2024. Front Public Health. 2024. PMID: 39697280 Free PMC article.
-
Prediction of promiscuous epitopes in ORF2 of Hepatitis E virus: an In-Silico approach.Afr Health Sci. 2022 Sep;22(3):626-639. doi: 10.4314/ahs.v22i3.67. Afr Health Sci. 2022. PMID: 36910344 Free PMC article.
-
Deep Insight Into Long Non-coding RNA and mRNA Transcriptome Profiling in HepG2 Cells Expressing Genotype IV Swine Hepatitis E Virus ORF3.Front Vet Sci. 2021 Apr 29;8:625609. doi: 10.3389/fvets.2021.625609. eCollection 2021. Front Vet Sci. 2021. PMID: 33996960 Free PMC article.
-
Development and Application of a Nanobody-Based Competitive ELISA for Detecting Antibodies against Hepatitis E Virus from Humans and Domestic Animals.Microbiol Spectr. 2023 Aug 17;11(4):e0360722. doi: 10.1128/spectrum.03607-22. Epub 2023 Jun 22. Microbiol Spectr. 2023. PMID: 37347160 Free PMC article.
References
-
- Arankalle V. A., Lole K. S., Deshmukh T. M., Srivastava S., Shaligram U. S. (2009). Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes. Vaccine 27 1032–1039. 10.1016/j.vaccine.2008.11.097 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources